SCHEMBL1585196

SCHEMBL1585196

Nc1ccnc(Cl)c1C(=O)NCCc1ccc(F)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 1/20 0.42
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
LMNA P02545 2/20 0.40
TAAR1 Q96RJ0 1/20 0.40
CMA1 P23946 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1585753 0.88 PPARG (0.47) CA1CA2CA9MEN1KMT2A
SCHEMBL1178732 0.82 TAAR1 (0.55) NPC1RAB9ALMNATAAR1SMN1; SMN2
SCHEMBL1585819 0.81 CA1 (0.42) NPC1RAB9ACA1CA2CA9
SCHEMBL20881242 0.79 MEN1 (0.54) NPC1RAB9ALMNASMN1; SMN2MEN1
SCHEMBL1585323 0.76 RAB9A (0.45) NPC1RAB9ALMNASMN1; SMN2GAA
SCHEMBL30309968 0.74 PPARG (0.47) MEN1KMT2A
SCHEMBL20402622 0.74 MEN1 (0.54) MEN1KMT2A
SCHEMBL1585418 0.74 PPARG (0.47) MEN1KMT2A
SCHEMBL10170740 0.73 ESRRG (0.48) NPC1RAB9ACA1CA2CA9
SCHEMBL1584870 0.72 NPC1 (0.42) NPC1RAB9ALMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2485731-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS Millennium Pharmaceuticals, Inc. (US) 2012-08-15 EP disclosed
WO-2011044157-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS BIOGEN IDEC MA INC. (US) 2011-04-14 WO disclosed